Articles Tagged With: COVID-19
-
Overcoming Vaccine Misinformation to Secure Staff Buy-In
Convincing staff a vaccine is important and safe will take a robust educational plan. Administrators can start by meeting with staff and encouraging them to ask questions. Leaders should emphasize the safety and efficacy data to dispel misinformation.
-
Rolling Out a COVID-19 Vaccine at Surgery Centers
Surgery center leaders should start educating staff about the vaccine candidates and create vaccine policies for employees and patients. Because vaccine demand is high, leaders also should prepare in case their facilities become designated vaccine administration sites.
-
AAFP, CDC Promote Immunizations Among Minority Populations
Groups recruiting family medicine practices for two initiatives.
-
Neurotropism of COVID-19: What Is New?
SARS-CoV-2 may gain access to the brain via the olfactory epithelium. The olfactory epithelium and bulbs may serve as an entry point for SARS-CoV-2 infection into the central nervous system.
-
Delayed Screenings Correlate with More Severe Lung Cancer Malignancies
COVID-19 led to canceled or delayed care in 2020 — with consequences.
-
Teletriage Applications Help EDs Improve Efficiency, Respond to COVID-19 Pandemic
As the demand for virtual care has accelerated, teletriage has melded well with other telemedicine innovations that may permanently change many of the ways in which emergency care is delivered. Some early adopters explain what pushed them out of the gate early, how teletriage has helped them manage the challenges posed by COVID-19, and how they see the approach evolving.
-
CDC Revises COVID-19 Quarantine Recommendations
Now, quarantine can end after 10 days without a COVID-19 test if the person has reported no symptoms, or after seven days with a negative test if the person has reported no symptoms.
-
The Work of Vaccinating Frontline Healthcare Workers Against COVID-19 Begins
Hospitals are scrambling to ensure a smooth and effective process for vaccinating frontline healthcare workers against COVID-19. Leaders need to quickly equip their personnel with enough information to persuade them that the vaccine is safe and effective.
-
Treatment of COVID-19 Patients with Remdesivir, Hydroxychloroquine, Lopinavir, or Interferon Beta-1a
None of the four drugs studied was superior to placebo.
-
Casirivimab + Imdevimab Injection
Casirivimab/imdevimab should be used to treat mild to moderate COVID-19 in adults and patients ≥ 12 years of age weighing at least 40 kg who have tested positive for SARS-CoV-2.